Recombinant Growth hormone response in Indian girls with Turner syndrome
International Journal of Clinical Endocrinology and Metabolism · 2018
DOI: 10.17352/ijcem.000029 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Clinical Endocrinology and Metabolism, 2018. Verfasst von Kochar Inderpal Singh. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Turner syndrome (TS) is characterized by short statute and ovarian dysgenesis in females with one X chromosome and partial or complete absence of the second X. It has an estimated birth prevalence of 1/2000 to 1/5000 female live births [1]. There is a global growth delay in TS characterized by slight intrauterine growth retardation, delayed growth during infancy and childhood, and lack of a pubertal growth spurt [2].
Zitieren
APA
Singh, K. I. (2018). Recombinant Growth hormone response in Indian girls with Turner syndrome. International Journal of Clinical Endocrinology and Metabolism. https://doi.org/10.17352/ijcem.000029
Vancouver
Singh KI. Recombinant Growth hormone response in Indian girls with Turner syndrome. International Journal of Clinical Endocrinology and Metabolism. 2018. doi:10.17352/ijcem.000029
BibTeX
@article{Singh2018,
author = {Singh, Kochar Inderpal},
title = {Recombinant Growth hormone response in Indian girls with Turner syndrome},
journal = {International Journal of Clinical Endocrinology and Metabolism},
year = {2018},
doi = {10.17352/ijcem.000029}
}
EUVIMED